The company has not filed an annual or quarterly report since its FY2021 10-K, filed Sep 2, 2021. Its latest SEC filing is a 4 from Dec 8, 2021.
10-K for FY2021, filed Sep 2, 2021
The sections below describe the company as of the FY2021 annual report.
Sells ultrasonic surgical devices, skin grafts, and wound-care products to hospitals, surgeons, and wound-care providers.
10-K for FY2021, filed Sep 2, 2021We design, manufacture, market, sell and distribute minimally invasive surgical ultrasonic medical devices. These products are used for…View ↗
These devices primarily serve the following clinical specialties: neurosurgery, orthopaedic surgery, general surgery, plastic surgery…View ↗
In the United States, we sell our products through our direct sales force, in addition to a network of commissioned agents assisted by…View ↗
Hospitals and distributors buy its medical products; product income is counted when goods ship or arrive, rental income month by month, and service income over contract terms.
10-K for FY2021, filed Sep 2, 2021The Company generates revenue from the sale and leasing of medical equipment, from the sale of consumable products used with medical…View ↗
Revenue derived from the shipping and billing of product is recorded upon shipment, when transfer of control occurs for products shipped…View ↗
Revenue derived from the rental of equipment is recorded on a monthly basis over the term of the lease. Shipments of consumable products to…View ↗
Revenue derived from service and maintenance contracts is recognized evenly over the life of the service agreement as the services are…View ↗
$22.2M
10-K, filed Aug 20, 2015
$22.2M ↗
In the United States, Misonix sells through its direct sales force and commissioned agents; outside the country, specialty distributors buy BoneScalpel and SonaStar and resell them to hospitals.
10-K for FY2021, filed Sep 2, 2021In the United States, we sell our products through our direct sales force, in addition to a network of commissioned agents assisted by…View ↗
Yes. It kept 25 cents of every revenue dollar as net income in .
10-K, filed Aug 20, 2015
8-K, filed Oct 29, 2021
As discussed in the Introductory Note, on October 29, 2021, the Mergers were consummated in accordance with the terms of the Merger…View ↗
Grew. Revenue grew 42% in 3 years, from $15.7M in to $22.2M in , about 12% a year.
Added wound-healing products
The earlier report described ultrasonic medical devices; the latest also describes marketing skin allografts and other wound-care products alongside those devices.
10-K for FY2018, filed Sep 13, 2018 10-K for FY2021, filed Sep 2, 2021Misonix, Inc. is a New York corporation based in Farmingdale, New York. We design, manufacture and market minimally invasive therapeutic…View ↗
We design, manufacture, market, sell and distribute minimally invasive surgical ultrasonic medical devices. These products are used for…View ↗
Moved neXus into its product lineup
The older report described the Nexus platform as under development; the latest describes neXus as an integrated system combining capabilities of existing surgical products.
10-K for FY2018, filed Sep 13, 2018 10-K for FY2021, filed Sep 2, 2021As of June 30, 2018, our Research and Development (“R&D”) organization consisted of a staff of 10 employees including engineers, technical…View ↗
Competes with Johnson & Johnson, Integra Life Sciences, Söering, Stryker, Smith & Nephew, MiMedx, and Organogenesis
10-K for FY2021, filed Sep 2, 2021Competition in the medical device products industry is rigorous. We believe that the principal competitive factors in our markets are…View ↗
Loading...
